Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Maintains Buy on Applied Digital, Lowers Price Target to $3.7

Needham analyst John Todaro maintains Applied Digital (NASDAQ:APLD) with a Buy and lowers the price target from $5.5 to $3.7.

byBenzinga Newsdesk

January 13, 2023

1 minute read

Needham analyst John Todaro maintains Applied Digital (NASDAQ:APLD) with a Buy and lowers the price target from $5.5 to $3.7.

Truist Securities Maintains Buy on Seacoast Banking, Lowers Price Target to $39

By Benzinga Newsdesk

Today, 12:55 PM

Truist Securities analyst Brandon King maintains Seacoast Banking (NASDAQ:SBCF) with a Buy and lowers the price target from $42 to $39.

SBCF

UBS Upgrades Pinduoduo to Buy

By Benzinga Newsdesk

Today, 12:55 PM

UBS analyst Jerry Liu upgrades Pinduoduo (NASDAQ:PDD) from Neutral to Buy.

PDD

Palantir, Tilray, Affirm See High WallStreetBets Interest But This Stock Tops The Charts Today

By Madhukumar Warrier

Today, 12:55 PM

SmileDirectClub Inc. (NYSE: SDC) has emerged as the most-discussed stock on Reddit’s r/WallStreetBets forum as on Wednesday night, while Palantir Technologies Inc.

AFRM

Regeneron Pharmaceuticals: Q2 Earnings Insights

By Benzinga Insights

Today, 12:55 PM

Shares of Regeneron Pharmaceuticals (NASDAQ:REGN) moved higher by 0.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 260.34% year over year to $25.80, which beat the estimate of $17.69.

REGN

Needham Maintains Buy on Applied Digital, Lowers Price Target to $3.7

Related Posts

Truist Securities Maintains Buy on Seacoast Banking, Lowers Price Target to $39

UBS Upgrades Pinduoduo to Buy

Palantir, Tilray, Affirm See High WallStreetBets Interest But This Stock Tops The Charts Today

Regeneron Pharmaceuticals: Q2 Earnings Insights